Clinical Trial Update: Tumor-Infiltrating Lymphocytes in Endometrial Cancer

View source ↗

Summary

A completed clinical trial evaluating tumor-infiltrating lymphocytes as a treatment for endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Jagiellonian University | Conditions: Endometrium Cancer, Tumor Infiltration | Status: COMPLETED